- Trans Catheter Aortic Valve Replacement
- Trans Catheter Mitral Valve Repair
Transcatheter Heart Valve Market size was valued at USD 6.33 billion in 2022, growing at a CAGR of 15% from 2023-29. Transcatheter heart valves (THV) are used to replace the heart valves with a prosthetic valve for treatment of severe aortic stenosis and mitral regurgitation. These heart valve diseases can be congenital or acquired later in life due to age related life style changes and may be other underlying diseases. If these are not treated can cause heart failure, stroke, blood clots, or death due to sudden cardiac arrest.Aortic stenosis is a condition when the aortic valve does not fully open, causing blood flow to be restricted. These high-risk patients are those who are ineligible for surgical aortic valve replacement (SAVR) and cannot be operated on. Transcatheter aortic valve replacement (TAVR) includes implanting new aortic valves to restore the aortic valve's capacity to circulate blood. Aortic stenosis is becoming more common, which has led to an increase in the requirement for transcatheter aortic valve implantation.
Fastest Growing Market
Transcatheter heart valve market is anticipated to grow at significant CAGR over the forecast period. Market players are focusing on investments in R&D to develop and launch various new and technologically advanced devices for making heart valve procedures safer and more effective and strengthening their positions in market. For instance, transcatheter aortic valve replacement or trans catheter aortic valve implantation has become novel procedures for patients who are considered high risk for standard valve replacement therapy. Apart from this, companies also focusing on mergers and acquisitions to enhance their market share. For instance in 2016, Edwards Lifesciences Corporation agreed to acquire Valtech Cardio Ltd., for trans catheter repair of mitral and tricuspid valves.
The transcatheter heart valve market size was valued at USD 6.33 billion in 2022
The key segments covered in the transcatheter heart valve market are: by product type, surgical procedure type and end-users
The transcatheter heart valve market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.